Research

Research at CTRID

Master
Content

The central focus of the Center for Translational Research on Inflammatory Diseases is to promote research by MEDVAMC-based BCM investigators, which represents a shared goal for MEDVAMC and BCM. Inflammatory diseases, defined broadly, provides a unifying theme for collaborative research.

Heading

High-Impact Manuscripts

Media Component
High-Impact Manuscripts
Content

The Center for Translational Research on Inflammatory Diseases Wall of Recognition recognizes center members who published manuscripts in high-impact journals. To date, 47 manuscripts have been acknowledged in this manner.

Heading

Recent Publications

Content

The following are some of the manuscripts published by CTRID investigators acknowledging their affiliation with our center; there have been more than 260 publications to date:

Heading

Recent Extramural Awards

Content

The following are some of the recently awarded and currently active extramural grants by CTRID investigators to which CTRID contributed, shown in descending chronological order of start date. Since inception our Center has contributed to the generation of new funding of over $63.4 million in total costs from 86 awarded grants.

  • Anatomic microniches and their contribution to vascular remodeling in pulmonary hypertension, VA-ORD BLR&D, Grant # I01BX004954, 10/01/2021-09/30/2025, Pandit L 
     
  • Molecular Studies of Hemolytic Thrombosis, NIH/NHLBI, Grant # R01HL154688, 06/01/2021-04/30/2025, Cruz M & Yee A 
     
  • Mechanisms of microvascular thrombosis in inflammation, VA-ORD BLR&D, Grant # I01BX002551, 04/01/2021-03/31/2025, Rumbaut R 
     
  • Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology, NIH/NCI, Grant # R01CA247917, 03/01/2021-02/28/2025, Vijayan V 
     
  • Lung Precision Oncology Program (LPOP), VA-ORD CSP, Grant # I50CU000161, 10/01/2020-09/30/2025, Kheradmand F & Cornwell L
     
  • G6PD Deficiency Predicts Outcomes from COVID-19 Infection amongst Veterans at Highest Risk for Severity of Illness, VA-ORD CSR&D COVID-19 Pilot, 10/01/2020-09/30/2021, Pandit L 
     
  • VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1), VA-ORD CSR&D COVID-19 Pilot, 10/01/2020-06/30/2021, Rodriguez-Barradas, M 
     
  • Brain Connectivity and Genetics as Predictors of Opioid Abuse Treatment Outcomes, VA-ORD CSR&D, Grant # I01CX001937, 10/01/2020-09/30/2024, Salas R 
     
  • Lifestyle Intervention Strategies to Reverse Frailty in Older Adults with Obesity, VA-ORD CSR&D Clinical Trial, Grant # I01CX002161, 10/01/2020-09/25/2025, Villareal D 
     
  • IMPACC-MEDVAMC, NIH/NIAID, Grant # R01AI135803, 09/01/2020-02/28/2022, Corry D & Kheradmand F 
     
  • Molecular and Cellular Dissection of miRNas in Controlling Allergic Airway Inflammation in Mice, VA-ORD BLR&D, Grant # I01BX004828, 07/01/2020-06/30/2024, Corry D 
     
  • Improving Treatment Algorithms for Veterans with Oropharyngeal Cancer, VA-ORD CSR&D CDA-2, Grant # IK2CX001953, 04/01/2020-03/31/2023, Sandulache V 
     
  • Hormonal Interventions for the Treatment in Veterans with COVID-19 Requiring Hospitalization (HITCH): A Multicenter, Phase 2 Randomized Controlled Trial of Best Supportive Care (BSC) vs BSC plus Degarelix, VA-ORD CSR&D COVID-19 Pilot, 04/01/2020-03/31/2021, Villareal R 
     
  • CMA: Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures, VA-ORD BLR&D, Grant # I01BX004633, 01/01/2020-06/30/2024, Wendt C & Kheradmand F
     
  • Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy, VA-ORD CSR&D, Grant # I01CX001822, 01/01/2020-03/31/2025, Yao Q